Executive Management Team


Bih Hsu, Ph.D.

Dr. Hsu earned his Ph.D. in analytical chemistry specializing in mass spectrometry from Purdue University under the direction of Professor Graham Cooks. He has more than 20 years of experiences in pharmaceutical research and development primarily focusing on analytical chemistry and DMPK/Bioanalysis in both drug discovery and drug development. Dr. Hsu's work includes numerous projects that have led to NDA and MAA approval. Prior to Joining PHARMout Laboratories Dr. Hsu was the Vice General Manager of QR Pharmaceuticals in Wuhan, China as a head of research responsible for innovative and generic drug research. He was an executive director of DMPK/Bioanalysis and CMC Analytical chemistry at Exelixis Pharmaceuticals from 2004 to 2014. Dr. Hsu's expertise is mainly on GLP Bioanalysis, DMPK screening, GMP analytical, unknown/metabolite identification and characterization using advanced analytical technologies. He is versed in GLP and GMP regulation, IND, NDA and MAA filing.



Patrick Lin, Ph.D.

Dr. Lin has more than 20 years of experience in contract research organization (CRO) for both drug discovery and drug development. After earning his Ph.D. in analytical medicinal chemistry and constructing the first LCMS with electrospray interface at Purdue University, Dr. Lin worked at MDS Pharma Services for 10 years as the Director of Mass Spectrometry and Senior Global Research Leader. He developed and validated numerous GLP bioanalytical methods with more than one hundred publications. Prior to Joining PHARMout Laboratories, Dr. Lin was the Vice President of Elim Biopharmaceuticals to lead bioanalysis, and implement lab automation of NextGen sequencing. He also previously was the Senior Director of Bioanalytical Services at Xenobiotic Laboratories, the Director of Pharma Services at Intertek to lead and develop GLP and OECD analytical services in the Asia region, and the founder of iPhase Pharma Services at Beijing, China. Dr. Lin is a current member of SQA and ASMS.



Allan Xu, Ph.D.

Dr. Xu obtained his PhD in biochemistry from University of Maryland at College Park in 1987. He has worked at both public and private sector laboratories for the last 30 years. Allan has pioneered the use and exploitation of mass spectrometry to provide analytical support for forensic, endocrinology, clinical toxicology, and pharmaceutical PK sample analysis. He is a co-founder at Keystone Bioanalytical, Inc. a LC/MS./MS based CRO located near Philadelphia where he held the position of Lab. Director since 1996. His main interest is using the most advance technology for small molecule/biomarker quantitation.


Copyright © 2018 Pharmout Laboratories, Inc. All rights reserved.